Article
Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants
10 Nov 2017
Abstract excerpt
BACKGROUND: Bronchopulmonary dysplasia (BPD) remains a major complication of prematurity and currently lacks efficient treatments. Mesenchymal stem/stromal cells (MSCs) have been extensively explored as a potential therapy in several preclinical and clinical settings. Human and animal MSCs have been shown to prevent and treat lung injury in various preclinical models of lung diseases, including experimental BPD....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
